Diuretics

High-yield Verified · Jul 2026

Agents that increase renal excretion of salt and water, grouped by their site of action in the nephron.

How it works in the body

The system involved, what goes wrong, and how the drug and body interact.

01 The nephron: how the kidney handles salt and water

Each kidney contains about a million filtering units called nephrons. A nephron first filters a huge volume of fluid from the blood, then reabsorbs most of the salt and water back as the fluid travels down the tubule — fine-tuning exactly how much is kept versus sent out as urine. Where sodium goes, water follows.

Sodium is reclaimed at several distinct stations along the tubule, each using a different transport protein: the thick ascending limb (a Na⁺-K⁺-2Cl⁻ pump that reclaims the most), the distal convoluted tubule (a Na⁺-Cl⁻ pump), and the collecting duct (under the control of the hormone aldosterone, which trades sodium for potassium). Each diuretic class targets one of these stations — and that single fact predicts its potency *and* its electrolyte side effects.

Loading diagram…

Sodium reabsorption sites along the nephron — one target per diuretic class.

02 Why we diurese — fluid overload

In heart failure, a weak pump lets blood back up, forcing fluid into the lungs (pulmonary edema) and legs. In kidney or liver disease, the body retains salt and water. In hypertension, excess volume contributes to the pressure. In all of these, removing sodium (and the water that follows) unloads the system — easing breathlessness and swelling and lowering blood pressure.

The trade-off is that flushing out sodium also disturbs the other electrolytes the tubule handles alongside it — which is where the class’s signature dangers come from.

03 How each class intervenes — and the electrolyte consequences

Loop diuretics (furosemide) block the most powerful reabsorption pump, so they produce the biggest diuresis — but they also dump potassium and magnesium, causing hypokalemia. Thiazides block a downstream, weaker pump — a gentler diuresis used for hypertension, also causing hypokalemia plus higher glucose and uric acid (gout). Potassium-sparing agents like spironolactone block aldosterone at the end of the tubule, so the kidney keeps potassium — the one class that causes hyperkalemia instead.

This is the crux of diuretic safety: loop and thiazide agents drive potassium down, spironolactone drives it up. Combining a loop or thiazide with spironolactone is often deliberate — the potassium effects offset.

Loading diagram…

The key split: loop/thiazide lower potassium; potassium-sparing agents raise it.

Drug names

Generic Brand

furosemide Lasix

bumetanidesemide Bumex

hydrochlorothiazide Microzide, HCTZ

spironolactone Aldactone

Indications

Edema of heart failure, hepatic, or renal origin (loop diuretics)
Hypertension (thiazides are first-line)
Acute pulmonary edema (IV loop diuretics)
HFrEF & hyperaldosteronism (spironolactone)

Mechanism of action

Loop diuretics inhibit the Na⁺-K⁺-2Cl⁻ cotransporter in the thick ascending limb (most potent). Thiazides inhibit the Na⁺-Cl⁻ cotransporter in the distal tubule. Potassium-sparing agents (spironolactone) antagonize aldosterone in the collecting duct, retaining potassium.

In plain terms

They make the kidneys pull extra salt and water out of the body, easing fluid overload and lowering blood pressure.

Therapeutic effects — what you'll see working

Success is measured concretely: falling weight, better intake/output balance, less edema and breathlessness, and lower blood pressure. Daily weight is the single most useful indicator — a kilogram of weight change is roughly a liter of fluid.

↓ Edema / fluid ↓ Blood pressure ↑ Urine output

↓ Edema / fluid: Removing sodium pulls the accompanying water out with it, relieving pulmonary congestion (easier breathing) and peripheral swelling. Loop diuretics do this most powerfully — the drug of choice for acute pulmonary edema.
↓ Blood pressure: Lower blood volume means less pressure in the vessels. Thiazides are first-line for hypertension because their gentler, sustained effect suits chronic control.
↑ Urine output: The visible, expected effect — verify it happens (especially after an IV loop dose), since it confirms the drug is working and drives the electrolyte monitoring that follows.

Adverse effects

Every major adverse effect is an electrolyte the tubule handles alongside sodium. The direction depends on the class: loop and thiazide push potassium down; potassium-sparing agents push it up.

Common

Loop & thiazide: hypokalemia, hyponatremia, hypomagnesemia, dehydration, orthostatic hypotension, hyperuricemia (gout), hyperglycemia (thiazide). Potassium-sparing: hyperkalemia, gynecomastia.

Hypokalemia is the headline effect of loop and thiazide agents — dangerous because low potassium provokes cardiac arrhythmias (and worsens digoxin toxicity). Thiazides also raise glucose and uric acid, so watch diabetics and gout patients. Spironolactone does the reverse — hyperkalemia — and, by blocking androgen effects, can cause gynecomastia.

Serious

Severe electrolyte depletion → cardiac arrhythmias; profound volume depletion and hypotension; loop ototoxicity.

Aggressive diuresis can drop volume and electrolytes fast enough to cause arrhythmias, hypotension, and acute kidney injury. Loop diuretics are also ototoxic — high doses or rapid IV push can cause tinnitus or hearing loss, so IV doses are given slowly.

■ Boxed warnings

Furosemide: profound diuresis can severely deplete water and electrolytes — titrate and monitor. Spironolactone: a tumorigen in rats — avoid unnecessary use.

Furosemide’s boxed warning is essentially a caution about potency: given in excess it causes profound fluid and electrolyte loss, so it must be titrated to the individual patient with close monitoring. Spironolactone’s reflects animal tumor data — use it only when indicated.

Contraindications

Contraindications follow the mechanism: don’t diurese a kidney that can’t make urine, and don’t give a potassium-sparing agent to someone already prone to high potassium.

Anuria (loop & thiazide)

If the kidney is not producing urine, a diuretic cannot work and simply risks toxicity.

Hyperkalemia, Addison’s disease, or concurrent K⁺ supplements — spironolactone

Spironolactone retains potassium; adding it to an already-high potassium state can cause fatal hyperkalemia.

Sulfonamide hypersensitivity (loop & thiazide) use caution

Loop and thiazide diuretics share a sulfonamide structure, so a true sulfa allergy is a caution/contraindication.

Severe existing electrolyte depletion or dehydration use caution

Further fluid and electrolyte loss could precipitate arrhythmias and circulatory collapse — correct first.

When to hold

Assess before giving — these findings mean hold the dose and act.

Symptomatic hypotension or severe electrolyte imbalance

Hold and notify the prescriber; correct the imbalance before further diuresis.

Labs & levels

Test Therapeutic / normal Toxic / critical

Electrolytes (K⁺, Na⁺) Baseline & routinely — loop/thiazide lower K⁺, potassium-sparing agents raise it Normal range K⁺ 3.5–5.0 · Na⁺ 135–145 mEq/L —

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Monitoring

Monitor electrolytes (K⁺, Na⁺, Mg²⁺), renal function, BP, and daily weight with intake/output.

Why: These drugs act by moving salt and water, so weight and electrolytes are the direct measures of both effect and harm; potassium especially drives arrhythmia risk.

Loop diuretics: assess hearing, and give IV doses slowly (e.g. furosemide ≤ 4 mg/min).

Why: Rapid, high-dose IV loop diuretics are ototoxic; slow administration prevents tinnitus and hearing loss.

Potassium-sparing agents: watch for hyperkalemia and avoid potassium supplements/salt substitutes.

Why: Spironolactone retains potassium, so added potassium can push levels into a dangerous, arrhythmogenic range.

Patient teaching

Take the dose in the morning (loop/thiazide) and rise slowly.

Why: Daytime dosing avoids nighttime bathroom trips (nocturia); orthostatic hypotension from volume loss causes dizziness and falls.

Report muscle cramps, weakness, or palpitations; with loop/thiazide agents, eat potassium-rich foods (bananas, oranges) as advised.

Why: These are symptoms of hypokalemia; replacing potassium (except with spironolactone) keeps levels safe and prevents arrhythmias.

Weigh daily at the same time and report a gain of 2–3 lb in a day or 5 lb in a week.

Why: A rapid weight gain signals returning fluid overload before symptoms worsen — an early warning to adjust therapy.

Sources

Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.